Immunotherapy has revolutionized cancer treatment. However, only one-third of patients respond
to the treatment. As these drugs are very expensive, it is of utmost importance to identify
biomarkers that can accurately predict response.
The human immune system plays a fundamental role in killing pathogens and tumors, while it is essential to tolerate healthy cells of the human body. Tumor immunotherapy has revolutionized cancer treatment in the previous two decades.
We are seeking Ph.D. students to join the Systems Immunology Research Group, within the Synthetic and Systems Biology Unit of the BRC. You will study antitumor immunity and peptide immunogenicity using large datasets and modern data analysis methods.